biochemical vs. clinical relapse, and when you need treatment
Published 4 years ago • 294 plays • Length 4:59Download video MP4
Download video MP3
Similar videos
-
6:19
when do you treat relapsed disease, and how is the right treatment selected?
-
4:12
biochemical relapse in multiple myeloma: to treat or not to treat?
-
4:41
defining relapsed and refractory myeloma; what's the difference?
-
3:25
what are the newest drugs and treatments for relapsed and refractory myeloma?
-
6:36
why is it important to be consulting with a myeloma specialist at relapse? #myeloma
-
28:40
all about talvey (talquetamab)
-
1:11:07
microbiome 101: learning about gut health for myeloma patients and caregivers
-
58:00
know your myeloma immunotherapy: teclistamab and other bispecifics
-
1:08
when should a patient consider a clinical trial at relapse?
-
1:59
optimal treatment sequencing for relapsed/refractory myeloma
-
3:06
when should we start treatment for relapsed multiple myeloma patients?
-
7:30
biochemical relapse of multiple myeloma
-
8:00
when should a patient consider changing a therapy?
-
4:24
monoclonal antibodies for myeloma relapsed after asct
-
5:46
treatment options in asymptomatic biochemical relapse in multiple myeloma
-
9:50
treatment for relapsed and refractory multiple myeloma
-
5:08
what is relapsed and refractory myeloma? | experts explain #myeloma
-
36:43
mcrt new york 2018: expert panel q&a on multiple myeloma (morning session)
-
4:44
relapsed/refractory multiple myeloma (rrmm): best practices in treating early rrmm
-
10:45
all about pomalyst (pomalidomide)
-
30:08
peter voorhees, md: approach to relapsed/refractory multiple myeloma: mcrt charlotte 2018